Pluri Inc
NASDAQ:PLUR

Watchlist Manager
Pluri Inc Logo
Pluri Inc
NASDAQ:PLUR
Watchlist
Price: 5.45 USD -9.77% Market Closed
Market Cap: 29.8m USD
Have any thoughts about
Pluri Inc?
Write Note

Pluri Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pluri Inc
Capital Expenditures Peer Comparison

Comparables:
CLGN
KMDA
B
BLRX
URGN
B
BONS

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Pluri Inc
NASDAQ:PLUR
Capital Expenditures
-$323k
CAGR 3-Years
5%
CAGR 5-Years
-6%
CAGR 10-Years
15%
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Capital Expenditures
-$954k
CAGR 3-Years
-22%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Capital Expenditures
-$9.4m
CAGR 3-Years
-40%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
B
BioLine RX Ltd
TASE:BLRX
Capital Expenditures
-$200k
CAGR 3-Years
-119%
CAGR 5-Years
54%
CAGR 10-Years
-3%
Urogen Pharma Ltd
NASDAQ:URGN
Capital Expenditures
-$234k
CAGR 3-Years
32%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Capital Expenditures
-â‚Ş464k
CAGR 3-Years
25%
CAGR 5-Years
-5%
CAGR 10-Years
8%

See Also

What is Pluri Inc's Capital Expenditures?
Capital Expenditures
-323k USD

Based on the financial report for Jun 30, 2024, Pluri Inc's Capital Expenditures amounts to -323k USD.

What is Pluri Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
15%

Over the last year, the Capital Expenditures growth was -23%. The average annual Capital Expenditures growth rates for Pluri Inc have been 5% over the past three years , -6% over the past five years , and 15% over the past ten years .

Back to Top